Prosthetic Heart Valve/ Artificial Heart Valve is expected to reach USD 8.86 billion by 2022

Thursday, June 15, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, June 14, 2017 /PRNewswire/ -- Highlights

ˇ         Prosthetic Heart Valves Market Projected to Grow

at a CAGR of 12.9% in the Forecast Period (2017 to 2022)

ˇ         The prosthetic heart valves market is projected to reach USD 8.86 billion by 2022, at a CAGR of 12.9% from 2017 to 2022.

ˇ         Transcatheter

Heart Valves to Register the Highest CAGR During the Forecast Period

ˇ         Based on the type of valve, the prosthetic heart valves market is categorized as transcatheter heart valves, tissue heart valves, and mechanical heart valves.

ˇ         The transcatheter heart valves segment is expected to register the highest CAGR during the forecasting period.

ˇ         Factors such as the rising prevalence of aortic stenosis, increasing pool of patients owing to approvals for extended valve indications, and technological advancements are supporting the growth of this segment.

ˇ         North America Is Estimated to Be the Fastest-growing Regional Segment in the Global Prosthetic Heart Valves Market During the Forecast Period

ˇ         In 2017, North America is expected to dominate the prosthetic heart valves market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW).

"Prosthetic Heart Valves Market Projected to Grow at a CAGR of 12.9% in the Forecast Period (2017 to 2022)"The prosthetic heart valves market is projected to reach USD 8.86 billion by 2022, at a CAGR of 12.9% from 2017 to 2022. The major factors driving the growth of this market include the rising geriatric population and the subsequent increase in the prevalence of HVD, regulatory approvals for new and advanced prosthetic heart valves, increasing government funding for heart valve research, rising awareness about HVD, and favorable reimbursement scenario for prosthetic heart valves."Transcatheter Heart Valves to Register the Highest CAGR During the Forecast Period"Based on the type of valve, the prosthetic heart valves market is categorized as transcatheter heart valves, tissue heart valves, and mechanical heart valves. The transcatheter heart valves segment is expected to register the highest CAGR during the forecasting period. Factors such as the rising prevalence of aortic stenosis, increasing pool of patients owing to approvals for extended valve indications, and technological advancements are supporting the growth of this segment."North America Is Estimated to Be the Fastest-growing Regional Segment in the Global Prosthetic Heart Valves Market During the Forecast Period"In 2017, North America is expected to dominate the prosthetic heart valves market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). This regional segment is also projected to register the highest CAGR during the forecast period. Factors such as the rapid growth in the aging population and prevalence of valvular heart diseases, favorable reimbursement scenario, and rising product approvals for heart valves are contributing to the growth of the North American prosthetic heart valves market.The key players in this market are Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil).

Download the full report: https://www.reportbuyer.com/product/4939881/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected]   Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/prosthetic-heart-valve-artificial-heart-valve-is-expected-to-reach-usd-886-billion-by-2022-300474091.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook